4-Bromo-3,5-dimethoxyamphetamine
Appearance
This article relies largely or entirely on a single source. (September 2019) |
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name
1-(4-Bromo-3,5-dimethoxyphenyl)propan-2-amine | |
Other names
4-Bromo-3,5-dimethoxyamphetamine
2-(4-Bromo-3,5-dimethoxy-phenyl)-1-methyl-ethylamine 2-(4-Bromo-3,5-dimethoxyphenyl)ethan-1-methyl-amine | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C11H17BrNO2 | |
Molar mass | 275.166 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
4-Bromo-3,5-dimethoxyamphetamine is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 4–10 mg and the duration is listed as 8–12 hours.[1] It produces analgesia, numbness, and reduction of physical feeling. Very little data exists about its pharmacological properties, metabolism, and toxicity.
See also
References